Oramed Pharmaceuticals (Israel) Technical Analysis

    ORMP -- Israel Stock  

    null 1,240  13.00  1.04%

    As of 25 of March Oramed Pharmaceuticals holds Risk Adjusted Performance of (0.14) and Coefficient Of Variation of (480.77). Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of Oramed Pharmaceuticals as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for Oramed Pharmaceuticals which can be compared to its competitors. Please check Oramed Pharmaceuticals Mean Deviation, Downside Deviation, Standard Deviation, as well as the relationship between Semi Deviation and Coefficient Of Variation to decide if Oramed Pharmaceuticals is priced some-what accurately providing market reflects its current price of 1240.0 per share.
    Horizon     30 Days    Login   to change

    Oramed Pharmaceuticals Technical Analysis

    Indicator
    Time Period
      Portfolio Suggestion  Portfolio Suggestion  
      
    Execute Indicator
     
    We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

    Oramed Pharmaceuticals Trend Analysis

    Use this graph to draw trend lines for Oramed Pharmaceuticals. You can use it to identify possible trend reversals for Oramed Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Oramed Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

    Oramed Pharmaceuticals Best Fit Change Line

    The following chart estimates an ordinary least squares regression model for Oramed Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 35.95 % which may suggest that Oramed Pharmaceuticals market price will keep on failing further. It has 78 observation points and a regression sum of squares at 1.276721116E7, which is the sum of squared deviations for the predicted Oramed Pharmaceuticals price change compared to its average price change.

    Diversify with Oramed Pharmaceuticals

    Build Optimal Portfolios

    Fix your portfolio
    By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Oramed Pharmaceuticals to your portfolio

    Oramed Pharmaceuticals Market Strength

    Oramed Pharmaceuticals March 25, 2019 Daily Price Condition

    Additionally take a look at Your Equity Center. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
    Search macroaxis.com